PRAX · earnings call history
Praxis Precision Medicines Q2 FY26 — Dual NDA Progress and Commercial Readiness
Read the briefPraxis Precision Medicines Q1 FY26 — Late-Stage Assets Progress, Commercial Ramp, and Pipeline Catalysts
Read the briefBrowse all US companies on the earnings-call register.